GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $2.77 $4.97 Friday, 19th Apr 2024 ALDX stock ended at $3.86. This is 3.02% less than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 5.28% from a day low at $3.79 to a day high of $3.99.
90 days $2.71 $4.97
52 weeks $1.42 $11.97

Historical Aldeyra Therapeutics prices

Date Open High Low Close Volume
2022-01-04 $4.30 $4.40 $4.14 $4.24 842 914
2022-01-03 $4.06 $4.29 $3.93 $4.27 1 004 853
2021-12-31 $4.16 $4.18 $3.94 $4.00 1 341 061
2021-12-30 $4.05 $4.23 $3.94 $4.06 1 124 077
2021-12-29 $4.10 $4.17 $3.95 $4.01 1 174 169
2021-12-28 $4.14 $4.47 $4.04 $4.06 1 190 856
2021-12-27 $4.17 $4.23 $3.98 $4.08 1 878 401
2021-12-23 $3.83 $4.22 $3.82 $4.17 2 355 758
2021-12-22 $3.46 $3.93 $3.37 $3.84 6 719 590
2021-12-21 $4.00 $4.07 $3.40 $3.50 13 094 984
2021-12-20 $6.93 $7.26 $6.84 $7.13 1 991 754
2021-12-17 $6.80 $7.33 $6.69 $7.04 2 958 363
2021-12-16 $7.11 $7.14 $6.66 $6.77 826 060
2021-12-15 $6.75 $7.15 $6.51 $7.10 1 050 196
2021-12-14 $6.95 $7.05 $6.70 $6.76 807 347
2021-12-13 $6.89 $7.27 $6.70 $7.01 797 943
2021-12-10 $7.06 $7.17 $6.89 $6.93 478 870
2021-12-09 $7.18 $7.43 $7.03 $7.05 460 426
2021-12-08 $7.40 $7.54 $7.26 $7.32 434 262
2021-12-07 $6.72 $7.51 $6.72 $7.33 1 094 083
2021-12-06 $6.91 $7.01 $6.57 $6.89 591 595
2021-12-03 $7.32 $7.40 $6.80 $6.89 673 324
2021-12-02 $7.47 $7.56 $7.13 $7.33 676 840
2021-12-01 $7.78 $7.99 $7.35 $7.38 1 079 197
2021-11-30 $7.13 $7.79 $6.97 $7.67 921 990
Click to get the best stock tips daily for free!

About Aldeyra Therapeutics

Aldeyra Therapeutics Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It also develops ADX-629, a first-in-class orally administered RASP modulator that is Phase II clinical tria... ALDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT